Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
3.800
+0.040 (1.06%)
At close: Nov 20, 2024, 4:00 PM
3.700
-0.100 (-2.63%)
Pre-market: Nov 21, 2024, 7:07 AM EST
Revance Therapeutics Market Cap
Revance Therapeutics has a market cap or net worth of $398.63 million as of November 21, 2024. Its market cap has decreased by -50.08% in one year.
Market Cap
398.63M
Enterprise Value
698.00M
1-Year Change
-50.08%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since February 6, 2014, Revance Therapeutics's market cap has decreased from $453.20M to $398.63M, a decrease of -12.04%. That is a compound annual growth rate of -1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 394.40M | -48.91% |
| Dec 29, 2023 | 771.90M | -49.18% |
| Dec 30, 2022 | 1.52B | 29.62% |
| Dec 31, 2021 | 1.17B | -37.87% |
| Dec 31, 2020 | 1.89B | 157.62% |
| Dec 31, 2019 | 732.10M | -1.68% |
| Dec 31, 2018 | 744.60M | -32.67% |
| Dec 29, 2017 | 1.11B | 87.35% |
| Dec 30, 2016 | 590.30M | -38.42% |
| Dec 31, 2015 | 958.60M | 138.58% |
| Dec 31, 2014 | 401.80M | -11.34% |
| Feb 6, 2014 | 453.20M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Biosciences of California | 429.97M |
| Quanterix | 429.08M |
| Foghorn Therapeutics | 428.62M |
| Esperion Therapeutics | 423.63M |
| Aquestive Therapeutics | 423.07M |
| DocGo | 408.20M |
| Contineum Therapeutics | 408.06M |
| Prime Medicine | 405.75M |